Skip to main content
. 2016 Aug 25;12:105–117. doi: 10.1016/j.ebiom.2016.08.036

Fig. 6.

Fig. 6

Immunohistochemical analysis of p53 target markers in molecular subtypes of bladder cancer. Note that in both luminal (GATA3 +; KRT5/6-) and basal (GATA3-; KRT5/6 +) subtypes, the p53-like tumors are showing the expression of SMA or desmin in the stromal component of the tumor while the tumor cells do not express these markers. Scale bars indicate 100 μM.